Bayer for ProfessionalsYour Resource Portal

PP-XAR-GB-3643 | February 2024

Cardiology Homepage

Products

Xarelto®

Protect what matters most for your eligible cardiovascular patients

Xarelto Prescribing Information

PP-XAR-GB-3601, February 2024

Cardiology Events & Webinars

Common Questions in the treatment of Venous Thromboembolism

Karen Breen

Xarelto® Prescribing Information

RP-XAR-GB-5151, February 2024

What are the key questions for Cancer Associated Thrombosis?

Dr Mari Thomas

Xarelto® Prescribing information

RP-XAR-GB-5149, February 2024

Video Resources on the topic of Venous Thromboembolism (VTE)

Expert advice in the management of VTE from National and International thought leaders

Xarelto® Prescribing Information

RP-XAR-GB-5156, February 2024

Common questions in the treatment of VTE

Dr Mari Thomas talks about the treatment of VTE in a series of short videos

Xarelto® (rivaroxaban) Prescribing Information

RP-XAR-GB-5302, February 2024

Cardiology Learning Zone

Module 4:

Motivational Interviewing

Xarelto® (rivaroxaban) Prescribing Information

RP-XAR-GB-5165, February 2024

Module 3

Motivational Interviewing CPD accredited course

Xarelto® (rivaroxaban) Prescribing Information

RP-XAR-GB-5164, February 2024

Module 2:

Motivational Interviewing CPD accredited course

Xarelto® (rivaroxaban) Prescribing Information

RP-XAR-GB-5163, February 2024

Module 1:

Motivational Interviewing CPD accredited course

Xarelto® (rivaroxaban) Prescribing Information

RP-XAR-GB-5162, February 2024

Cardiology Resources

Xarelto® (rivaroxaban) Patient Support Materials

Access useful, downloadable cardiovascular resources for patients

Xarelto Prescribing Information

PP-XAR-GB-3537, February 2024

To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.

Areas of Interest

Reporting adverse events and quality complaints

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Bayer plc.

If you want to report an adverse event or quality complaint, reports can be directed to Tel: 0118 206 3500 or Email: pvuk@bayer.com.

Further information is available on the "contact" tab at www.bayer.co.uk.